ScoliScore™ AIS Prognostic Test
Today, there is an alternative — a predictive test that provides increased peace of mind for patients, their families, and clinical care providers.
It's called the ScoliScore™ AIS Prognostic Test .
The ScoliScore™ Prognostic Test is a clinically validated, multi-gene test that provides a qualitative and quantitative assessment of the likelihood of spinal curve progression for patients who have been diagnosed with AIS. The ScoliScore™ AIS Prognostic Test is paving the way for individualized scoliosis treatment by providing patient-specific information that is used to help health care providers optimize treatment plans.
The ScoliScore™ AIS Prognostic Test is intended for patients:
- With a primary diagnosis of AIS
- Between the ages of 9 and 13 years old
- With a mild scoliotic curve (defined as <25°)
- Of Caucasian ethnicity (North American, South American, European, Eastern European, Middle Eastern)
Click here to be notified when new ScoliScore™ AIS Prognostic Test information is added to this site.
In addition to the ScoliScore™ AIS Prognostic Test, other products are currently in development including genetic tests for:
- Degenerative Disc Disease
- Spondyloslisthesis
- Scheuermann's Disease
- Osteoarthritis
- Osteoporosis
Click here to learn about participating in clinical trials or research studies for the above spinal conditions.
